{"text": "first disclosure of irak 4 degrader nx 0479 gs 6791 gild just paid nrix 20m to exercise opt in gs 5718 study is now marked withdrawn cris pfe rigl kymr"}
{"text": "we are excited to announce that gild has exercised its option to license nurixs irak4 targeted protein degrader as part of our discovery collaboration agreement learn more here tpd autoimmunedisease rheumatoidarthritis"}
{"text": "5 calls 5 puts from our methodology tickers ready to move watchlist for 3 21 23 watch 1 3 days calls sgml bili ally gild csco puts lazr nclh c sgfy gm suggest several strikes otm no 0dte scale out at 30 and 60 leave runners we alert you trade"}
{"text": "gild nrix gilead licenses protein degrader from nurix therapeutics"}
{"text": "amih majority owned subsidiary epiq scripts obtains controlled substance registration from the u s department of justice amp drug enforcement administration ibb nvs amgn pfe gild dea"}
{"text": "krtx i would think if i was a company like gild i probably would buy krtx over mdgl given moa and furture competition"}
